Results 171 to 180 of about 48,363 (248)

PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial. [PDF]

BMJ Open
Chen Z, Ma S, Zhang J, Zhang R, Zhou M, Li C, Chen Y, Wang H, He Y, REPRESS trial investigator.   +9 more
europepmc   +1 more source

Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Adv Ther
Masson W, Lobo M, Giunta G, Barbagelata L, Nogueira JP.   +4 more
europepmc   +1 more source

Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement. [PDF]

Am J Prev Cardiol
Nguyen DQ, Hwang J, Rohatgi A, Joshi PH, Khera A, Peterson ED, Navar AM.   +6 more
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 [PDF]

Angiology, 2013
openaire   +2 more sources

A feasibility study on predicting disease progression in high-grade gliomas using magnetic resonance imaging habitat radiomics based on response assessment in neuro-oncology (RANO) criteria. [PDF]

Digit Health
Zhu Y, Jiang G, Sun X, Qiu L, Shi K, Wu M, Fei Y, Yuan J, Luo J, Li Y, Cao Y, Xu W, Zhou S.   +12 more
europepmc   +1 more source

Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. [PDF]

Medicine (Baltimore)
Peng S, Liu M, Du F, Li K.
europepmc   +1 more source

Dramatic Coronary Artery Aneurysm Regression After Coronary Artery Bypass Grafting and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy. [PDF]

Interdiscip Cardiovasc Thorac Surg
Yokoyama Y, Higashino H, Fujieda H, Abe M.   +3 more
europepmc   +1 more source

Dissecting the molecular mechanisms of T cell infiltration in psoriatic lesions <i>via</i> cell-cell communication and regulatory network analysis. [PDF]

Open Life Sci
Li K, Ge X, Shang Y, Jiao Y, Dong L, Yu Y.   +5 more
europepmc   +1 more source